LAG3-PD1 trgeting bispecific antibody (Shandong Fontacea Pharmaceutical)

N/A

Report date: 2024/03/26 14:49:51

Base Information

Drug NameLAG3-PD1 trgeting bispecific antibody (Shandong Fontacea Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsProgrammed cell death protein 1 inhibitors
TargetsLymphocyte activation gene 3 proteinProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A